UK expert committee recommends Pfizer, Moderna COVID-19 vaccines for pregnant women
The Joint Committee on Vaccination and Immunisation (JCVI) said around 90,000 pregnant women had been vaccinated in the United States, mainly with the two American vaccines, without any safety concerns being raised
Pfizer Ltd - 500680 - Compliance Certificate - Regulation 40 (9) Of The SEBI (LODR) Regulations, 2015
In compliance with Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Certificate given by the Practicing Company Secretary, M/s. Manish Ghia & Associates, for the half year ended March 31, 2021. PFIZER LTD. - 500680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we furnish herewith Certificate dated April 13, 2021, issued by KFin Technologies Private Limited, Registrar and Share Transfer Agent of the Company for the quarter ended March 31, 2021. We request you to take the same on record. PFIZER LTD. - 500680 - Compliance Certificate - Regulation 7(3) Of The SEBI (LODR) Regulations, 2015
In compliance with Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Certificate from the Company and the Registrar and Share Transfer Agent for the half year ended March 31, 2021. Pfizer Ltd - 500680 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 036360 Name of the Signatory :- PRAJEET NAIRDesignation :- Company Secretary and Compliance Officer
India may have to wait for a few months for Pfizer, JJ jabs: Report
The Union health ministry has fast-tracked approvals for foreign-made COVID-19 vaccines that have been granted emergency use authorisation in other countries.
Pfizer to pursue bringing COVID-19 vaccine to India after easing of import rules
We have noted the recent announcement with regard to the regulatory pathway for global vaccines, a Pfizer spokesperson said
After US, South Africa suspends use of Johnson & Johnson Covid-19 vaccine
South African Health Minister Zweli Mkhize on Tuesday said that the country will be suspending the use of the Johnson & Johnson COVID-19 vaccine after health concerns raised by the US Food and Drug Administration (FDA)."We have determined to voluntarily suspend our rollout until the causal relationship between the development of clots and the Johnson and Johnson vaccine is sufficiently interrogated," Mkhize said in a statement."In the extremely unlikely event that Johnson and Johnson rollout is completely halted, we will not have any impediment to proceed with phase two of the rollout with Pfizer," he added.This comes after the US Centers of Disease Control and Prevention (CDC) and the FDA recommended a "pause" in the use of the Johnson and Johnson COVID-19 vaccine "out of an abundance of caution" over six reported cases in the US of a "rare and severe" type of blood clot.In a joint statement, the CDC and the FDA said they were investigating clots in six women in the days after .
COVID-19 vaccination: Japan starts inoculating people aged 65 and above amid fourth wave
Shots for people aged 65 and above began at some 120 sites across the country, using Pfizer Inc's vaccine made in Europe and delivered to the regions in the past week
South African coronavirus variant can 'break through' Pfizer vaccine: Israel study
The study, released on Saturday, compared almost 400 people who had tested positive for Covid-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients with the disease